Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
DHI Group
DHX
$171M
| $462K | ﹤0.01% |
220,390
-13,416
| -6% | -$34.5K |
|
3402
Lifetime Brands
LCUT
$226M
| $461K | ﹤0.01% |
68,550
+673
| +1% | +$3.61K |
|
3403
Intrepid Potash
IPI
$493M
| $460K | ﹤0.01% |
46,448
-4,490
| -9% | -$46.6K |
|
3404
Exicure
XCUR
$7.97M
| $460K | ﹤0.01% |
1,258
+899
| +250% | +$326K |
|
|
ARA
3405
DELISTED
American Renal Associates Holdings, Inc
ARA
| $458K | ﹤0.01% |
70,196
+164
| +0.2% | +$1.06K |
|
3406
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.24B
| $457K | ﹤0.01% |
8,331
+1,053
| +14% | +$56.9K |
|
3407
Altimmune
ALT
$572M
| $454K | ﹤0.01% |
42,410
| – | – |
|
|
PFSW
3408
DELISTED
PFSweb, Inc.
PFSW
| $454K | ﹤0.01% |
67,954
+32,693
| +93% | +$173K |
|
3409
Valhi
VHI
$459M
| $451K | ﹤0.01% |
43,011
+6,420
| +18% | +$68.4K |
|
|
ALSK
3410
DELISTED
Alaska Communications Systems
ALSK
| $451K | ﹤0.01% |
161,527
+104,585
| +184% | +$238K |
|
3411
Colony Bankcorp
CBAN
$473M
| $450K | ﹤0.01% |
38,223
+1,600
| +4% | +$18.6K |
|
3412
Evolus
EOLS
$538M
| $449K | ﹤0.01% |
84,625
+2,682
| +3% | +$12.4K |
|
3413
X4 Pharmaceuticals
XFOR
$418M
| $447K | ﹤0.01% |
1,597
+299
| +23% | +$81.9K |
|
|
ZAGG
3414
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $446K | ﹤0.01% |
141,958
-86,510
| -38% | -$272K |
|
|
CMCT
3415
Creative Media & Community Trust
CMCT
$14M
| $445K | ﹤0.01% |
2
| – | – |
|
3416
Veru
VERU
$46.5M
| $443K | ﹤0.01% |
13,270
+11,020
| +490% | +$379K |
|
3417
First Bank
FRBA
$471M
| $442K | ﹤0.01% |
67,881
-1,326
| -2% | -$9.38K |
|
3418
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.69B
| $441K | ﹤0.01% |
28,862
-7,173
| -20% | -$105K |
|
3419
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $438K | ﹤0.01% |
13,900
-4,576
| -25% | -$138K |
|
|
APTX
3420
DELISTED
Aptinyx Inc. Common Stock
APTX
| $438K | ﹤0.01% |
105,074
+63,893
| +155% | +$216K |
|
|
CASI
3421
DELISTED
CASI Pharmaceuticals
CASI
| $436K | ﹤0.01% |
17,464
+678
| +4% | +$14.7K |
|
3422
ENI
E
$79.8B
| $435K | ﹤0.01% |
22,622
-7,398
| -25% | -$142K |
|
|
PBIP
3423
DELISTED
Prudential Bancorp, Inc.
PBIP
| $435K | ﹤0.01% |
36,093
+417
| +1% | +$4.96K |
|
3424
Mayville Engineering Co
MEC
$614M
| $434K | ﹤0.01% |
54,897
+4,807
| +10% | +$29.5K |
|
3425
Nomura Holdings
NMR
$28.7B
| $432K | ﹤0.01% |
97,334
-2,090
| -2% | -$8.7K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.